AcouSort AB (ACOU) - Total Liabilities

Latest as of September 2025: Skr3.21 Million SEK ≈ $345.34K USD

Based on the latest financial reports, AcouSort AB (ACOU) has total liabilities worth Skr3.21 Million SEK (≈ $345.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AcouSort AB cash flow conversion to assess how effectively this company generates cash.

AcouSort AB - Total Liabilities Trend (2013–2024)

This chart illustrates how AcouSort AB's total liabilities have evolved over time, based on quarterly financial data. See ACOU net asset value for net asset value and shareholders' equity analysis.

AcouSort AB Competitors by Total Liabilities

The table below lists competitors of AcouSort AB ranked by their total liabilities.

Company Country Total Liabilities
Eifelhöhen-Klinik AG
F:EIF
Germany €23.59 Million
Trive Property Group Bhd
KLSE:0118
Malaysia RM10.99 Million
Jcurve Solutions Ltd
AU:JCS
Australia AU$5.61 Million
Newport Exploration
V:NWX
Canada CA$95.81K
Ubis (Asia) Public Company Limited
BK:UBIS
Thailand ฿556.77 Million
Galilee Energy Ltd
AU:GLL
Australia AU$4.94 Million
Kesla Oyj A
HE:KELAS
Finland €19.34 Million
Locate Technologies Ltd
AU:LOC
Australia AU$5.58 Million

Liability Composition Analysis (2013–2024)

This chart breaks down AcouSort AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of AcouSort AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AcouSort AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AcouSort AB (2013–2024)

The table below shows the annual total liabilities of AcouSort AB from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 Skr3.86 Million
≈ $415.51K
-62.80%
2023-12-31 Skr10.38 Million
≈ $1.12 Million
-53.96%
2022-12-31 Skr22.54 Million
≈ $2.43 Million
+537.14%
2021-12-31 Skr3.54 Million
≈ $380.75K
-1.15%
2020-12-31 Skr3.58 Million
≈ $385.16K
+69.38%
2019-12-31 Skr2.11 Million
≈ $227.39K
+13.60%
2018-12-31 Skr1.86 Million
≈ $200.17K
+74.81%
2017-12-31 Skr1.06 Million
≈ $114.50K
-48.94%
2016-12-31 Skr2.08 Million
≈ $224.27K
+1044.60%
2015-12-31 Skr182.07K
≈ $19.59K
-66.51%
2014-12-31 Skr543.60K
≈ $58.50K
-74.88%
2013-12-31 Skr2.16 Million
≈ $232.88K
--

About AcouSort AB

ST:ACOU Sweden Biotechnology
Market Cap
$8.97 Million
Skr83.39 Million SEK
Market Cap Rank
#27142 Global
#596 in Sweden
Share Price
Skr3.94
Change (1 day)
-2.72%
52-Week Range
Skr2.13 - Skr4.05
All Time High
Skr31.61
About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more